Bengaluru-based Centre for Cellular and Molecular Platforms (C-CAMP), has signed a Memorandum of Understanding (MoU) with Blockchain for Impact (BFI), a philanthropic organisation, to join the BFI-Biome Virtual Network, a catalyst, that will nurture cutting-edge biomedical science and innovation and accelerate impact of transformative scientific advances in moving the needle for key healthcare challenges in India.

The pact was exchanged at C-CAMP premises in Bengaluru by C-CAMP Director-CEO, Dr Taslimarif Saiyed and Dr Gaurav Singh, CEO, BFI in the presence of Dr Satya Prakash Dash, Senior Advisor, BFI and Dr Pooja Agrawal, Programme Director, BFI.

C-CAMP has a robust pipeline of biomedical innovations in several critical areas such as infectious disease diagnostics, antimicrobial resistance, cell therapy, immuno-oncology, regenerative tissues, digital health tech to name a few. At least ten of these solutions are already in clinical trials or at pre-IND stage with FDA or CDSCO. With the support of BFI, C-CAMP plans to jumpstart the last-mile sprint to commercialisation of these important emerging solutions by providing access to more state-of-the-art infrastructure, regulatory networks, funding and scale-up opportunities.

BFI will allocate over $200,000 over the course of three years, leveraging C-CAMP’s expertise to develop essential programmes for healthcare-based startups. C-CAMP being an organisation to foster deep science research and innovation for societal impact, the goals and mandates of both partners naturally align and complement each other. The partnership is expected to blur disciplinary boundaries in approaching biotech R&D, promote cross-integration of expertise and infrastructure, provide multidisciplinary insights into need identification, problem-solving and solution implementation.